Madagascar HIV AIDS Industry Outlook 2022 - 2026

See how Madagascar HIV AIDS performed compared to key markets such as Swaziland, Cape Verde and Latvia.

Key Market Indicators

Malagasy HIV AIDS treatment coverage is set to rise to 19% by 2026, up from 15% in 2021. This is an average yearly increase of 3.5%. Since 2009, the market has grown by 20.1%. In 2021, Malagasy ranked 134th, with Mauritius in the lead at 15%. Cape Verde, Latvia and Zimbabwe came in at 2nd, 3rd and 4th place respectively. Malagasy HIV AIDS prevalence is estimated to reach 2,660 people aged 0-14 by 2026, growing at a rate of 3.3% year-on-year. Since 1995, demand has increased by 9.1% annually. In 2021, Malagasy ranked 50th, while Gambia held the lead with 2,160 people aged 0-14. Nigeria, Mozambique and Tanzania came in 2nd, 3rd and 4th place respectively.

Madagascar HIV AIDS Market Data and Forecasts

How much will Madagascar HIV AIDS Market grow to 2026?

Forecast: Antiretroviral Therapy Coverage in Madagascar
Forecast: Incidence of Tuberculosis (Including HIV-Positive Cases) in Madagascar

Other Top Countries about HIV AIDS